Breaking News
December 14, 2018 - Blood test helps identify distinct molecular signatures in children with cystic fibrosis
December 14, 2018 - Scientists use water to track electrical activity of nerve cells
December 14, 2018 - Recurrence of urinary tract infection may depend on bacterial strain, study shows
December 14, 2018 - GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA)
December 14, 2018 - Partial Thromboplastin Time (PTT) Test: MedlinePlus Lab Test Information
December 14, 2018 - Common tactics for health promotion at work may be detrimental to employees with obesity
December 14, 2018 - Myths about migration and health not supported by available evidence
December 14, 2018 - Recent findings on rare genetic disorder may help develop new treatment options
December 14, 2018 - New drug shows promise in treating sarcomas
December 14, 2018 - Scientists perform lung lavage as new approach for tuberculosis diagnosis in rhinoceros
December 14, 2018 - Recent winners of the Nobel Medicine Prize
December 14, 2018 - KHN’s ‘What the Health?’ Insurance enrollment is lagging — and there are lots of reasons why
December 14, 2018 - Study assesses safety and efficacy of new treatment for pancreatic cancer
December 14, 2018 - Study finds drug targets for Ebola, Dengue, and Zika viruses
December 14, 2018 - Study highlights need for personalized approach to treat ICU acquired delirium
December 14, 2018 - Soot particles from road traffic significantly contribute to air pollution
December 14, 2018 - Massage helps relieve pain, improve mobility in patients with knee osteoarthritis
December 14, 2018 - Researchers explore home healthcare nurses’ knowledge attitudes toward infection control
December 14, 2018 - Average outpatient visit in the U.S. costs nearly $500, shows new study
December 14, 2018 - Reference Infliximab, Biosimilar Equivalent for Crohn’s Disease
December 14, 2018 - New contact lens to treat eye injuries
December 14, 2018 - Acne could have a genetic basis find researchers promising new cure
December 14, 2018 - Higher physical activity associated with improved mood
December 14, 2018 - New UGA study points to optimal hypertension treatment for stroke patients
December 14, 2018 - Study highlights factors that can reduce food cravings
December 14, 2018 - Researchers discover Ebola-fighting protein in human cells
December 14, 2018 - Fentanyl surpasses heroin in cause of U.S. drug overdose deaths
December 14, 2018 - When Heart Attack Strikes, Women Often Hesitate to Call for Help
December 14, 2018 - A warning about costume contacts
December 14, 2018 - Study examines link between peripheral artery disease and heart attack
December 14, 2018 - Researchers develop biotechnological tool to produce antifungal proteins in plants
December 14, 2018 - 3D-printed adaptive aids can benefit patients with arthritis
December 14, 2018 - Chronic bullying during adolescence impacts mental health
December 14, 2018 - Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics
December 13, 2018 - Importance of cell cycle and cellular senescence in the placenta discovered
December 13, 2018 - Gold “nanoprisms” open new window into vessels and single cells
December 13, 2018 - Research findings could lead to new targets for cancer-fighting therapeutics
December 13, 2018 - Butantan Institute signs collaboration agreement with MSD to develop dengue vaccines
December 13, 2018 - Study explores how patients want to discuss symptoms with doctors
December 13, 2018 - RUDN medics first to gather scattered data on hepatitis morbidity in Somalia
December 13, 2018 - Age and gender disparities found in use of bed nets to prevent malaria in sub-Saharan Africa
December 13, 2018 - Caffeine therapy benefits developing brains of premature babies
December 13, 2018 - New review focuses on electrospinning techniques used in musculoskeletal tissue engineering
December 13, 2018 - A new division focused on human immune system
December 13, 2018 - Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of Fintepla (ZX008) in Dravet Syndrome
December 13, 2018 - BCR ABL Genetic Test: MedlinePlus Lab Test Information
December 13, 2018 - Caffeinated beverages during pregnancy linked to lower birth weight babies
December 13, 2018 - Stanford Medicine Health Trends Report examines opportunity to democratize health care
December 13, 2018 - Obsessive-compulsive disorder may protect individuals from obesity
December 13, 2018 - Scientists investigate how a painful event is processed in the brain
December 13, 2018 - Genetic study reveals new insights into underlying causes of moderate-to-severe asthma
December 13, 2018 - Study uncovers new genetic clues to frontotemporal dementia
December 13, 2018 - Vitamin C supplementation for pregnant smokers may reduce harm to infants’ lungs
December 13, 2018 - New study reveals yin-yang personality of dopamine
December 13, 2018 - Research identifies nerve-signaling pathway behind sustained pain after injury
December 13, 2018 - Children with high levels of callous traits show widespread differences in brain structure
December 13, 2018 - Long-term Benefit of Steroid Injections for Knee Osteoarthritis Challenged
December 13, 2018 - Adding new channels to the brain remote control
December 13, 2018 - In the Spotlight: A different side of neuroscience
December 13, 2018 - Medical Marvels: Using immunotherapy for melanoma that spread to the brain
December 13, 2018 - Puzzles do not keep dementia away finds study
December 13, 2018 - New mouse model shows potential for rapid identification of promising muscular dystrophy therapies
December 13, 2018 - Study reveals urban and rural differences in prenatal exposure to essential and toxic elements
December 13, 2018 - New collaborative partnership in quest of novel antibiotics
December 13, 2018 - Single tau molecule holds clues to help diagnose neurodegeneration in its earliest stages
December 13, 2018 - AHA Scientific Statement: Low Risk of Side Effects for Statins
December 13, 2018 - What Is Acute Flaccid Myelitis?
December 13, 2018 - How bereaved people control their thoughts without knowing it
December 13, 2018 - Health care democratization underway, according to 2nd annual Stanford Medicine Health Trends Report | News Center
December 13, 2018 - Going Beyond a Single Color
December 13, 2018 - London-based startup launches ‘thedrug.store’ aiming to clean up CBD industry
December 13, 2018 - Loss of tight junction barrier protein results in gastric cancer development
December 13, 2018 - Novel way to efficiently deliver anti-parasitic medicines
December 13, 2018 - RKI publishes new data on disease prevention and utilization of medical services
December 13, 2018 - High-tech, flexible patches sewn into clothes could help to stay warm
December 13, 2018 - The CCA releases three reports on requests for medical assistance in dying
December 13, 2018 - Restoring Hair Growth on Scarred Skin? Mouse Study Could Show the Way
December 13, 2018 - Probiotic use may reduce antibiotic prescriptions, researchers say
December 13, 2018 - Drug repositioning strategy identifies potential new treatments for epilepsy
December 13, 2018 - Chronic rhinitis associated with hospital readmissions for asthma and COPD patients
A step forward in Parkinson’s disease

A step forward in Parkinson’s disease

image_pdfDownload PDFimage_print

It is widely known that genomics has already begun to influence medicine and that bioinformatics holds the key for developing new medical approaches, but how does medical genomics really work? Researchers at the Centre for Genomic Regulation (CRG) in Barcelona, in collaboration with scientists at the Barcelona Supercomputing Centre (BSC) and the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), have provided a clear example of how genomics is changing medicine.

The team, led by ICREA research professor Gian Gaetano Tartaglia at the CRG, is using genomics to advance our understanding of Parkinson’s disease. As published this week in Nucleic Acids Research, they have discovered a mechanism that regulates the expression of alpha-synuclein, a protein linked to Parkinson’s disease and multiple system atrophy (MSA).

Parkinson’s disease is the second most common human neurodegenerative disorder after Alzheimer’s disease. It is a multifactorial disorder in which genetic susceptibility, aging and environmental factors converge to cause neurodegeneration. The pathological hallmark of this disease is the accumulation of alpha-synuclein, which in turn leads to cell death, and consequently, to problems in neurotransmission.

In an attempt to understand how this protein is produced, these researchers first predicted interactions between the alpha-synuclein gene and other factors found within neurons. “We used the catRAPID algorithm developed in our lab to predict which proteins interact with the RNA product of this gene. Although our method revealed several candidates, we decided to test the ones that are more relevant for Parkinson’s disease and multiple system atrophy,” explains Gian Gaetano Tartaglia. “Computational predictions are already key in biomedical research, allowing us to better target our bench experiments and to be faster and more innovative when searching for solutions to medical questions,” he says.

Thanks to these predictions, the scientists at the CRG, together with the team of Fina Martí at IDIBAPS, were able to screen and validate the candidates in vitro (via cell culture), in vivo (with mice), and ex vivo, using human brain samples from dead patients. In this way, factors were deemed relevant or not for the development of Parkinson’s disease and MSA. “We found two factors—TIAR and ELAVL1—that are crucial in neurodegeneration. Identifying these factors is relevant for further understanding Parkinson’s disease and multiple system atrophy,” adds Elias Bechara, CRG researcher and one of the authors of the article. “Further research is needed, but thanks to our contribution, we have now identified two new biomarker candidates. For example, these factors might be useful for early detection of the diseases through a simple blood analysis, or even serve as new targets for possible treatment,” says the researcher.

The research is particularly relevant for patients with multiple system atrophy (MSA). MSA is a rare and aggressive neurodegenerative disorder, and many patients with this disorder do not respond to the dopamine medication used to treat Parkinson’s disease. Moreover, MSA is even more difficult to diagnose.

The new study shows that one of the factors (TIAR) especially binds the alpha-synuclein protein in MSA patients. “It is always rewarding to find something that might be helpful for a particular disease, but in this case, it is even more relevant since it could also be a good biomarker to facilitate MSA diagnosis,” say the researchers.


Explore further:
Drug discovery: Alzheimer’s and Parkinson’s spurred by same enzyme

More information:
Domenica Marchese et al, Discovering the 3′ UTR-mediated regulation of alpha-synuclein, Nucleic Acids Research (2017). DOI: 10.1093/nar/gkx1048

Journal reference:
Nucleic Acids Research

Provided by:
Center for Genomic Regulation

Tagged with:

About author

Related Articles